View Clinical Trial (Medical Research Study)

Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females - NCT00813319-30236(Clinical Trial 487552)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Jonesboro
State:  
GA
Zip Code: 30236
Conditions: Vaccination
Purpose: African American adolescent females seeking treatment for STIs are an underserved population at increased risk for HPV infection. While GARDASIL is an effective preventive vaccine, vaccination rates are low. Given the risk for HPV infection among this subgroup and the negative health effects associated with HPV, enhancing uptake of GARDASIL is necessary. To address this need, the proposed study is an exciting opportunity to build upon a relationship previously formed between Planned Parenthood of Georgia and Emory University Rollins School of Public Health. The goal of this project is to promote GARDASIL vaccination through the development of a new multi-component, culturally-appropriate, interactive DVD. We propose to recruit 400 unmarried African American adolescent females, 13-18 years of age, from Planned Parenthood in Atlanta, Georgia. At Planned Parenthood, adolescents will be contacted and invited to participate in the proposed study. Eligible adolescents will be required to provide written assent/consent prior to participation. Adolescents who are eligible and willing to participate in the project will complete a short survey on a laptop computer. The survey is designed to assess adolescents' risk taking and preventive behaviors. After they complete the survey, adolescents will be assigned at random to one of two groups. In one group, adolescents will watch a short (10 min), interactive DVD designed to promote HPV awareness and initial GARDASIL vaccination and receive a keepsake to help them remember to return to the clinic for their second and third vaccine doses. In the second group, adolescents will watch an equally short (10 min) DVD on healthy lifestyles and behaviors. All adolescents are eligible to receive the GARDASIL vaccine at Planned Parenthood as part of their routine standard of care. With the help of clinic staff, participant medical records will be reviewed over a 6 month period to assess vaccination rates. Vaccination rates from adolescents who received the interactive HPV/GARDASIL awareness DVD will be compared to the group of adolescents who received the healthy lifestyles DVD. It is hypothesized that study participants receiving the interactive DVD intervention that promotes HPV awareness will have higher vaccination rates over time.
Study summary:
Criteria: Inclusion Criteria: - African American - Female - Age 13-18 years - Seeking services at participating clinic - Ability to give written informed consent or assent Exclusion Criteria: - Pregnant - Married - Already received the HPV vaccine
Study is available at: Clayton County Board of Health
Jonesboro, GA 30236
United States

Primary Contact:
Colleen C. Murray, DrPH, MPH
Email: ccritte@sph.emory.edu
Phone: 404-727-9872
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.